CTRI/2012/11/003114已完成未知
Aripiprazole supplementation in Risperidone induced hyperprolactinemia: A randomized, double blind placebo controlled trial.
ICMR0 个研究点目标入组 30 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients with Schizophrenia who were maintaing well on Tab Risperidone atleast 4 mg for the minimum duration of 12 weeks
排除标准
- •Patient who is having serious medical illness
- •Patient who is having seizure disorder
- •Patient who requires dose modification
- •Patients who were not able to give consent
研究者
相似试验
招募中
3 期
Aripiprazle in ADHD and ODDIRCT20160530028182N5Sanandaj University of Medical Sciences60
已完成
2 期
aripiprazole versus risperidone for treating schizophreniaschizophrenia.SchizophreniaIRCT201305233930N26Shiraz University of Medical sciences60
招募中
3 期
Treating obsessive-compulsive disorder in patients with Bipolar disorderCondition 1: Bipolar disorder. Condition 2: Obsessive-Compulsive disorder.Obsessive-compulsive disorderBipolar disorderIRCT20200614047761N1Babol University of Medical Sciences60
Unknown
2 期
Comparison of Risperidone vs Aripiprazole in amphetamine induced psychotic disorderamphtamine induced psychotic disorder.F 15 .150 - F 15 .151 - F 15 .159F 15 .15IRCT201205029620N1Kermanshah university of medical sciences38
已完成
2 期
The Comparison of Aripiprazole versus Risperidone in Attention Deficit Hyperactivity DisorderAttention Deficit Hyperactivity Disorder.Hyperkinetic disordersIRCT2013050413215N1Vice Chancellor for Research, Shahid Beheshti University of Medical Sciences40